EMBA from Peking University
Joined Asymchem Group in 1999
Co-CEO of Asymchem Group and CEO of the emerging business units Clin-nov Medical and AsymBio
Over the past 20 years, Ms. Yang made significant contributions guiding the company to become a leading global pharmaceutical outsourcing service enterprise
Master of Finance from Tsinghua University PBC School of Finance
Previously worked at China Securities Regulatory Commission, with over 15 years of experience in stock market
Extensive experience in corporate listing, investment and financial management
Primarily responsible for the R&D, process development, production process transfer/scale-up of the biologics CDMO at AsymBio and the related work at CBTI
Previously worked at Hillhouse Group, World Health Organization headquarters. Center for Drug Evaluation, National Institutes for Food and Drug Control, and National Medical Products Administration
Has more than 26 years of experience in professional biologics development, production and registration
Master of Chemistry from University of Science and Technology of China
Over 15 years of global business development experience, and possesses extensive expertise in company management, including areas such as brand promotion, business expansion, team building
Ph.D. in Analytical Chemistry from Purdue University (W. Lafayette, IN)
Served as Director of Scientific Operations at Waters Corp.
Has 20+ years of working experience in analytical method development and quality control for biologics. Holds many US patents, and has published close to 50 scientific papers and book chapters
Master of Biology from the State University of New York at Buffalo and Bachelor’s Degree in Biochemistry from Fudan University
Has 30+ years of experience in traditional pharmaceutical and biopharmaceutical companies in the U.S. and China, spanning from QA/compliance, QC, validation, registration, and production
Served as Quality Manager or Plant Manager in Bristol-Myers Squibb Shanghai, Wyeth Pharmaceuticals, and Immunomedics (Gilead) in the U.S., Qilu Pharmaceuticals, CStone Pharmaceuticals, and other well-known companies
Previously worked at National Institute for Biological Standards and Control (NIBSC)/Medicines and Healthcare products Regulatory Agency (MHRA), UK, as Senior Scientist to Principal Scientist in the Physico-Chemical Analysis area, for 14 years
Has extensive experiences in analysis of biologics, regulation, quality control, and standard development, as well as the development and establishment of biological reference standards
Graduated from Zhejiang University in 2003 with Master of Biochemical Engineering
Formerly served in senior management positions for process development and production in well-known enterprises such as Innovent Biologics and Hisun Pharmaceuticals
Has more than 20 years of experience in the process development, technology transfer, and commercial production of monoclonal antibodies, fusion proteins, and other large molecule biopharmaceuticals, and has extensive experience in cGMP production of clinical as well as commercial products
Bachelor’s degree from Beihang University and MBA from Tsinghua University
Previously worked at Johnson & Johnson, Longfor, Tencent, etc.
Has close to 20 years of experience in human resources management, organizational development, subsidiary operations, and innovative business management for group companies
Master of Engineering from the University of Electronic Science and Technology of China
Previously worked at the Office of the Tianjin Development Zone Management Committee, the Public Affairs Center of the Tianjin Development Zone Authority, the Tianjin TEDA International Pioneer Center, and the Public Security Bureau of the Ministry of Transport
